FDA inspection

Mayor Pharmaceutical Laboratories, Inc: FDA inspection ending Nov 8, 1999

FDA inspection 3151 · Tempe, AZ

Key facts

Inspection ID 3151
Firm Mayor Pharmaceutical Laboratories, Inc
FEI number 2024825
Address 3015 S 48th St Ste 101
City Tempe
State AZ
ZIP 85282-3137
Fiscal year 2000
Inspection end date Nov 8, 1999
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections